Universitas Syiah Kuala | ELECTRONIC THESES AND DISSERTATION

Electronic Theses and Dissertation

Universitas Syiah Kuala

    SKRIPSI
Sania Adha Mellinia, STUDI PENERIMAAN DOSIS BOOSTER VAKSIN COVID-19 DI INDONESIA DAN PREDIKTOR YANG MEMENGARUHINYA PADA TAHUN 2023. Banda Aceh Fakultas Kedokteran,2023

Penyakit coronavirus disease 2019 (covid-19) disebabkan oleh severe acute respiratory syndrome coronavirus 2 (sars-cov-2) pertama terjadi di wuhan. vaksinasi efektif untuk mencegah covid-19 dengan cara menginduksi long-term immune memory. tujuan dari penelitian ini adalah untuk mengetahui penerimaan dosis booster vaksin covid-19 di indonesia dan prediktor yang memengaruhinya. jenis penelitian ini adalah analitik observasional dengan desain cross-sectional dan teknik pengambilan sampelnya simplified snowball sampling. total responden sebanyak 2245 yang didapatkan dengan cara pengisian kuesioner dan analisisnya menggunakan regresi logistik. sebanyak 90% responden cenderung lebih menerima dosis booster vaksin covid-19. hasil uji multivariat menunjukkan persepsi risiko vaksin covid-19 kategori rendah lebih berhubungan sebesar 7,9 kali, dibanding kategori rendah dan kategori tinggi dalam penerimaan dosis booster (or: 7,91; 95% ci: 3,02-20,74; p



Abstract

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first occurred in Wuhan. Vaccination is effective for COVID-19 prevention by inducing long-term immune memory. The purpose of this study was to determine the acceptance of booster doses of the COVID-19 vaccine in Indonesia and the predictors that influence it. This type of research is observational analytic with a cross-sectional design and simplified snowball sampling technique. A total of 2245 respondents were obtained by filling out a questionnaire and analyzed using logistic regression. A total of 90% of respondents were more likely to accept a booster dose of the COVID-19 vaccine. The results of the multivariate test showed that the risk perception of the COVID- 19 vaccine in the low category was more associated with 7.9 times, compared to the low and high categories in the acceptance of booster doses (OR: 7.91; 95% CI: 3.02-20.74; p



    SERVICES DESK